Lv31
240 积分 2024-07-10 加入
POS1135 Discovery and Characterization of Novel Oral TNF-Alpha Inhibitors as Potential Treatments for Autoimmune Diseases
2小时前
求助中
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
3天前
已完结
Plasma Protein Binding as an Optimizable Parameter for In Vivo Efficacy
2个月前
已完结
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
3个月前
已完结
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway
3个月前
已完结
Trends in the drug target landscape for autoimmune diseases
3个月前
已完结
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
4个月前
已完结
New molecular targets in the treatment of rheumatoid arthritis
4个月前
已完结
Facts and hopes of CD40 agonists as a cancer immunotherapy
4个月前
已完结
Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide
5个月前
已完结
皖公网安备34019202002308
